Tiffreau V, Viet G, Thevenon A: Pain and neuromuscular disease: the results of a survey. Am J Phys Med Rehabil 2006;85:756 -766. Objective: The objective of this study was to evaluate pain frequency, severity, location, treatment, and relief in a population of adult patients with neuromuscular disorders (NMD).
Neuromuscul ar diseases (NMDs) include a group of inherited or acquired diseases that affect the muscles or motor neurons. The prevalence of NMD in northern Europe is estimated at between 1 in 2900 and 1 in 3500. [1] [2] [3] The major symptom is muscle weakness, causing progressive motor disability and, occasionally, muscle contractures and scoliosis. Contractures are related to prolonged static positioning of the limb and often develop soon after a period of wheelchair reliance. 4 In the medical literature, there are few reports of pain as a major feature of NMD, although it is commonly described in inherited neuropathy (when painful sensory impairment occurs) and in inflammatory muscle disease. 5 Myalgia and cramps are sometimes the first symptoms of mild dystrophinopathies. 6 Bushby et al. reported four cases of facioscapulohumeral dystrophy presenting disparate muscle pains that the authors were unable to relate to inflammation. 7 A recent article has described the results of a survey of 193 patients affected by a variety of NMDs. The authors report rates of 73% for pain and 27% for severe pain (i.e., Ն7 on a 0 -10 scale), indicating that pain is common and undertreated in this population. 8 In our experience, patients frequently report severe, persistent pain that is sometimes difficult to localize and explain. Equally, the use of analgesic drugs in these pathologies is not clearly described and needs to be better evaluated.
We present the results of a survey of adult patients with NMD at Lille University Medical Center's Physical Medicine and Rehabilitation (PMR) clinic (northern France). A multidimensional selfcompletion questionnaire was sent by mail. Our survey aimed at 1) estimating the prevalence of pain and chronic pain; 2) describing pain in terms of its intensity and location; 3) examining the association among pain, anxiety, and depression; and 4) identifying the major pain-aggravating situations and vs. reviewing pain treatments by asking patients about medication, participation in physical therapy, and consultations with specialists. The variables were computed for the sample as a whole and among different subgoups (i.e., diagnosis groups, groups of subjects with chronic pain vs. subjects with acute pain and groups of walking subjects with pain vs. nonwalking subjects with pain).
METHOD Population
Two hundred eighty-one questionnaires were mailed to former and current patients of the Lille University Medical Center's PMR clinic. One hun-dred twenty-five patients returned the questionnaire (response rate ϭ 45%). All the patients were followed up at least once a year at the Lille University Medical Center's PMR clinic. The latter is funded by the French Myopathy Association and seeks to assist all adult patients with NMD in the Nord-Pas-de-Calais region of northern France. Most of the patients fell into the "muscle dystrophy" group, which includes fascioscapulohumeral dystrophy (FSHD), limb girdle muscle dystrophy (LGMD), and Duchenne and Becker muscular dystrophy (DMD and BMD). In the present study, all patients were aged 18 or over and had a confirmed diagnosis of NMD. Patients for whom a clear diagnosis or confirmatory molecular genetic analysis was not available were excluded from the survey.
Diagnosis frequencies in the contacted population and in the respondents are described in Table 1 . Of the 125 respondents, 15% had FSHD, 12% from myotonic muscular dystrophy (MMD), 12% from DMD and BMD, 12% from spinal muscular atrophy (SMA), 11% from LGMD, 8% from hereditary motor and sensory neuropathy (Charcot Marie Tooth disease [CMT]), and 30% from other muscular diseases.
Procedures
A self-completion questionnaire and an information form were sent by mail with a stamped return envelope. A numbering system enabled us to authenticate the diagnosis.
Measures
The questionnaire was divided into the following four chapters.
Identification
In this chapter, participants were asked to provide demographic information such as gender, age, and weight.
The presence of contractures was documented by answering "yes" or "no" to questions such as "Are you affected by contractures of the hip/knee/ ankle?" Function deficiency was assessed according to the upper and lower limits of the Brooke and Vignos functional ratings, which were designed and validated for clinical evaluation. 9,10 From a list of nine graded, functional activities for the lower limbs and six for the upper limbs, the patient had to identify which activities he or she was able to perform without help. Hence, the questionnaire provided a lower limb functional score on a 1-9 scale and an upper limb functional score on a 1-6 scale. A lower limb score of 3 or more signified that the subject was able to walk. Use of orthoses or assistive ambulation devices was also reported.
Pain Description
The questionnaire's second chapter investigated pain intensity, severity, and location. It also assessed anxiety and depression. Patients were asked to indicate whether they had experienced any pain in the past 3 wks. Chronic pain was identified by a question establishing whether the pain in question had started more than 3 mos previously. 11 The intensity of the worst pain experienced was rated on a 0 -10 numeric scale (0 ϭ no pain at all; 10 ϭ the worst pain imaginable). There is good evidence to support the validity of this type of pain intensity rating scale. [12] [13] [14] Pain location was assessed using a drawing of the body on which the respondent identified the location(s) where he or she felt pain. The drawing was divided into nine main regions (head, shoulder, elbow, wrist, spinal column, abdomen, hip, knee, and ankle) and the number of different pain locations was reported.
Anxiety and depression were evaluated using the Hospital Anxiety and Depression Scale (HADS). 15 This scale is frequently used in clinical practice and its French translation shows good reliability and sensitivity. 16 It provides a 0 -21 depression score and a 0 -21 anxiety score, which can thus be related to the risk of anxiety or depression. Lepine et al. have shown that scores of 11 of 21 or more are highly sensitive in terms of detecting anxiety or depression. 16 
Pain-Aggravating Situations
In the third chapter, situations that potentially increased or provoked pain were identified by a multiple-choice questionnaire. From a list of 10 items (standing, walking, muscle stretching, dressing, washing, transfers, sitting, lying in the supine position, massage, and wearing an orthosis), the patients had to choose those they considered as aggravating or provoking pain. The list of situations that could aggravate or provoke pain was established by a French Myopathy Association expert group, which includes physicians and physical medicine specialists who are particularly involved in NMD care. In our questionnaire, the respondent was asked to consider whether each situation listed was relevant to their own pain experience.
Pain Treatment
The fourth chapter investigated the categories of health professionals whom the patient had visited, the frequencies of such visits, and the use of painkillers and physical pain treatments. The amount of relief that each treatment provided was measured on a 0-to 100-mm analog visual scale (AVS).
Data were collected in a medical file to verify information concerning the diagnosis. The procedure was approved by the French National Committee for Personal Data Protection in accordance with Article 5, Paragraph 3 of the Governmental Act dated January 6, 1978.
Statistical Analysis
To address the first two study aims concerning the prevalence of pain, its intensity and location, percentages of the sample reporting pain, average pain intensity, and percentages of pain at different sites were computed for the sample as a whole as well as among diagnostic groups, the acute pain vs. chronic pain groups, and the walking vs. nonwalking patients with pain. The population with pain was divided in two groups: 1) participants with moderate pain (pain rated 5 or 6 on a 0 -10 scale); and 2) participants with severe pain (pain rated 7 or more on a 0 -10 scale). The frequency of moderate and severe pain was computed for the sample as a whole and for the diagnostic groups. 2 tests were used to determine whether the frequency of pain differed between the diagnostic groups, the acute pain vs. chronic pain groups and the walking vs. nonwalking subjects with pain. Nonparametric Wilcoxon tests and Mann-Whitney tests were used to determinate whether the intensity of pain was different between the diagnostic groups, the acute pain vs. chronic pain groups and the walking vs. nonwalking subjects with pain.
To study the association among pain, anxiety, and depression, Pearson correlation coefficients were computed between the pain intensity ratings and the HADS anxiety and depression scores in those participants who reported pain. In addition, the study sample was divided into three groups: 1) participants who did not report any pain (pain rated as 0 -2 on a 1-10 scale); 2) participants who reported mild or moderate pain (pain rated as 3-6 on a 1-10 scale); and 3) participants who reported severe pain (pain rated 7 or more on a 1-10 scale). HADS anxiety and depression scores in these three groups were compared using an analysis of variance (ANOVA) followed by univariate test if the ANOVA showed a significant group effect.
Addressing the fourth aim (identifying painaggravating situations), frequencies of pain-aggravating situations were computed for the sample as a whole for the chronic and acute pain groups and for both walking and nonwalking patients with pain, and 2 tests were used to determine whether the frequency of pain-aggravating situations differed between these groups.
Percentage frequencies of pain treatments use and the corresponding average level of relief were computed for the sample as a whole. Table 2 shows the respondents' characteristics in terms of gender, age, time since disease onset, weight, functional ability, and percentage with contractures.
RESULTS

Demographic, Clinical, and Functional Data
The mean age was 41 Ϯ 14.5 yrs (range, 18 -74 yrs), the mean time since disease onset was 19.1 yrs (range, 6 -53 yrs), and 20% of participants reported knee and ankle contractures.
The mean lower limb motion deficiency score on the Vignos scale was 6 (Ϯ 2.9) out of 9, and 70% of the individuals could still walk. The mean scores for the FSHD, MMD, and CMT populations were all above 7 out of 9, indicating good ambulatory capacity. The other pathology groups had a mean Vignos score of less than 7 out of 9. The mean upper limb motion deficiency score on the Brooke scale was 4.9 (Ϯ 1.2) out of 6 for the total population. The mean scores for the DMD, BMD, FSHD, and SMA populations were all lower than 5 out of 6. Thirty percent of the individuals required a wheelchair and 22% required a motorized wheelchair; wheelchair use was more frequently reported in the DMD and BMD and SMA populations (over 50% of the latter patients reported wheelchair use). Only two patients (those with DMD) were receiving respiratory support. Table 3 reports pain frequency and severity for all subjects with pain and as a function of NMD diagnosis. Seventy-three percent (73%) of individuals reported at least one episode of pain over the previous 3 wks and 62% reported chronic pain. The DMB and BMD population reported the highest frequency of chronic pain (67%) and the CMT population reported the lowest value (30%). Differences between diagnostic groups were not significant. The average pain intensity was 6.1 Ϯ 2.1, and the CMT population reported the highest average intensity (7.2 Ϯ 1.9). However, the figures showed high variability, and the differences between NMD diagnostic groups in terms of average pain intensity were not significant.
Frequency of Pain and Pain Intensity
Severe pain (as defined by pain rated 7 or more on a 0 -10 scale) was reported by 40% of all subjects and most frequently in the "other diagnosis" group (53%).
Differences between groups (diagnostic groups, acute pain vs. chronic pain groups and walking vs. nonwalking patients with pain) were not significant. Because the results in acute pain vs. chronic pain groups and walking vs. nonwalking patients did not significantly differ from the sample as a whole, they are not presented. Table 4 reports pain locations in the population with pain. Forty-six percent of the individuals reported at least three pain sites and 58% reported at least two pain sites. The most frequently re-ported pain sites were the spinal column (81%) and shoulder (54%). Pain locations did not differ between groups (diagnostic groups, acute pain vs. chronic pain groups and walking vs. nonwalking patients with pain).
Pain Location
In response to an open question about the potential cause of pain, the most frequently evoked words were: "muscle" (27%), "back" (27%), "effort" (21%), and "fatigue" (14%) in the population with pain.
Association among Pain, Anxiety, and Depression
Average anxiety and depression scores are reported in Table 5 .
The Pearson correlation coefficients between pain intensity and HADS anxiety score was low (r ϭ 0.29; P Ͻ 0.0001) as well as the Pearson correlation coefficients between pain intensity and HADS depression score (r ϭ 0.36; P Ͻ 0.0001).
The ANOVA showed a significant group effect for the depression score (P Ͻ 0.05), which was significantly higher in the "severe pain" group. This test did not show any significant effect for the anxiety score (P Ͻ 0.08). Table 6 reports percentage frequencies of painaggravating situations in all subjects with pain, in the groups of subjects with chronic and acute pain, and in the groups of walking and nonwalking subjects with pain. The pain-aggravating situations most frequently cited by patients with pain were "standing" (68%) and "walking" (67%). In terms of the NMD diagnostic groups, 60% of the FSHD population identified "standing" as a pain-aggravating situation and 67% of the MD population identified "walking" and "washing" as pain-aggravating situations. Percentages for "walking" and "standing" were significantly higher in the chronic pain group (62 and 57%, respectively) than in the acute pain group (36 and 36%, respectively). The "walking" and "standing" values were also higher for walking patients with pain (86 and 94%, respectively) compared with nonwalking patients with pain (31 and 7%, respectively). Percentage frequencies for the "transfers," "sitting," and "lying in the supine position" items were significantly higher in nonwalking subjects with pain (75, 75, and 57%, respectively) than in walking subjects with pain (29, 39, and 33%, respectively).
Pain-Aggravating Situations
Pain Care Evaluation
Ninety percent of the respondents had informed their immediate relatives of the presence of pain. Fifty-three percent had visited their general practitioner to ask for pain treatment. The neurologist was the specialist most likely to be consulted for advice on pain treatment. Table 7 reports the percentage frequencies for the various pain treatments used by subjects with pain together with the average relief associated with each treatment. Ninety percent of the individuals with pain had taken painkillers. The mean analgesic effect was evaluated using a relief score on a 100-mm VAS. Medial treatments were categorized according to the World Health Organization's three-step classification for cancer pain relief. 17 As can be seen, step 1 analgesics (nonnarcotics, nonsteroidal antiinflammatory drugs) was the treatment most often used for pain management (44%). The highest mean relief score was 47 Ϯ 22 for step 3 analgesics. The most frequent physical treatment consisted of massage (48%) with a mean analgesic relief score of 34 Ϯ 17. Other physical pain treatments reported were balneotherapy (23%), transcutaneous electroneurostimulation (TENS, 10%), and ultrasound (7%).
DISCUSSION
Our survey of adult patients with NMD aimed at evaluating the frequency, severity, and treatment of pain. The results indicate that pain occurs in many of these patients and that it is likely to be chronic and severe.
In 1998, our group performed a survey investigating access to current diagnostic techniques for patients with NMD in the Nord-Pas-de-Calais region of northern France; it notably revealed certain difficulties in obtaining consultations with specialists. Although the survey did not focus on the existence of pain per se, the authors nevertheless suggested that pain evaluation had not been sufficiently well evaluated in this population. 18 The present study did not seek to identify the medical causes of pain but it did focus on evaluating the prevalence of pain and the latter's various characteristics (duration, severity, and location) in patients with NMD. An additional aim was to estimate the efficacy of pain care in this population.
Clinical and Functional Data
We observed a high rate of lower limb contractures (25% for knee contractures) in agreement with the rate reported by Donze in a similar population (24%). 18 The MSA and DMDB groups showed the highest contracture rates (53% for knee contractures in the SMA population and 33% in the DMDB population). Johnson estimates that patients who have SMA and DMDB are more likely to develop severe contractures compared with other NMD groups. In a population of 230 patients with NMD, he reported 67% of knee contractures (defined as more than a 20-degree loss of passive joint motion) in the patients with DMD and 58% in the SMA population. 4
Pain Incidence, Intensity, and Location
Our results showed that 73% of the respondents had experienced pain in the previous 3 wks, which agrees quite well with the results of the recent survey published by Jensen et al. who reported the same frequency (73%) in a similar patient population having experienced pain during the 3 mos before their survey. 8 In the present study, all NMD diagnostic groups indicated a pain frequency of 60% or more, with the BMD and DMD group indicated the highest pain frequency (87%).
Pain seems to be more frequent in NMD than in other neurologic disorders. Williams recently estimated that pain was present in 66% of neurology outpatients. 19 According to Kong, chronic pain is present in 42% of stroke survivors. 20 Pain seems to be the most common complaint in a polio population, with a frequency of 44% for chronic pain. 21 Ehde reported that 44% of patients with multiple sclerosis experience persistent pain. 22 Very few data concerning the frequency of chronic pain in NMD have been published in the medical literature. In terms of dystrophynopathies, myalgia is frequently reported as a symptom when muscle destruction occurs. 23 Ishigaki has suggested that myalgia and cramps could be early manifestations of mild Becker disease. 6 Willig also described more frequent pain with contractures in a young population of patients with dystrophinopathy and those with MSA. 24 According to Oberlander, walking is associated with pain in CMT. 25 In a clear description of four cases of FSHD, Bushby identified pain as the most disabling symptom. Because the results of metabolic investigations and muscle biopsy did not reveal any clues as to the pathogenesis of this pain, he concluded that it was probably myalgic in nature and not the result of metabolic or inflammatory disorders. 7 Nevertheless, no investigations were made to determine the nature and prevalence of pain in these pathologies.
The present survey's value of 60% for chronic pain in all subjects is a high figure, because chronic pain frequency in the general population ranges from 2 to 45%. 26 -29 Interstudy differences in frequencies depend, of course, on the definition of chronic pain and the investigative method used. 30 We considered pain to be chronic when a patient affirmed that "pain has been present for at least 3 mos." 12 We did not find any significant differences in chronic pain frequencies as a function of NMD diagnosis. It seems that all types of NMDs showed a high rate of chronic pain despite heterogeneous physiopathologies and severities. The mean pain intensity in all subjects on the 0 -10 scale was high (6.1 Ϯ 2.1), bearing in mind that the mean AVS score of a nonchronic, malignant pain population is close to 7.1. The figure reported here is comparable with the average score observed by Jensen et al. in a similar population (5.06 Ϯ 2.5). 8, 31 The high observed variability (in light of high standard deviations) ruled out significant differences in average pain intensity between diagnosis groups.
Frequent pain locations in the population with pain were the spine (81%) and proximal joints (54% for shoulder pain and 47% for hip pain). This result is in agreement with the survey of patients with CMT published by Carter et al. and with the survey of patients with various NMDs published by Jensen et al.; both studies reported that the back was the most frequent pain location in these populations. 5, 8 Jensen et al. also reported high frequencies of back, leg, and shoulder pain in a similar population to that studied here (49, 47, and 43%, respectively). 8 There was no statistically significant link between the presence of contractures and the existence of pain or chronic pain. However, we can hypothesize that the pain site seems to correspond to the most common muscle weakness location in this type of population.
We noted that 79% of patients with pain reported more than two pain locations, and 63% of patients with pain even reported three or more pain locations. This indicates that clinical evalua-tion should not focus unduly on a single pain location.
The answers to the open question about the potential causes of pain suggest that pain could indeed occur in patients who experience a high amount of muscle fatigue. Pain associated with fatigue or a sensation of weakness should be further explored in an NMD population.
Association Among Pain, Anxiety, and Depression
An aim of the study was to evaluate the association among pain, anxiety, and depression in an NMD population. Higher risks for anxiety and depression have been described in patients with chronic, nonmalignant pain. 31 The correlation scores between pain intensity on the one hand and anxiety and depression on the other were low (0.29 and 0.36, respectively; P Ͻ 0.001), which is inconsistent with the pain literature. Nevertheless, depression scores were significantly higher in the severe pain group. These results showed that the NMD population with severe pain seems to have a risk for depression, but, in our sample, anxiety does not seem to be increased with pain intensity.
Anxiety and depression have principally been studied in SMD (Steinert Muscular Dystrophy) and amyotrophic lateral sclerosis (ALS) populations. In an ALS population, Tedman found that pain was associated with a higher risk for depression, but that the frequency of depression was similar to the value recorded in a control population with other causes of disability. 32 Although depression was considered to be a frequent symptom in DMS, a recent study did not confirm this association. 33, 34 We did not find that the DMS population had particularly high anxiety and depression scores in general. However, we did find a high risk of anxiety Step I (nonnarcotics, nonsteroidal antiinflammatory drugs) b 44 33 21 Step II (mild opioids) b 24 28 17 Step III (strong opioids) b  9  4 7  2 2  Narcotics  4  30  11  Muscle relaxants  5  23  12  Muscle stretching  22  33  23  Massage  48  34  17  Balneotherapy  23  28  23  Transcutaneous electroneurostimulation  10  21  12  Ultrasound  7  27  17 a Patients rated the amount of relief provided on a 0 (does not relieve the pain) to 100 mm (completely relieves the pain) visual analog scale.
b According to the World Health Organization's classification for the use of analgesics in cancer pain.
in the dystrophinopathy (64%) and FSHD populations (72%).
Pain-Aggravating Situations
An aim of the survey was to identify painaggravating situations in the sample as a whole and to study if these situations differ with the loss of walking ability as well as the presence of chronic pain in contrast to the presence of acute pain. In the list of situations that could aggravate or provoke pain, "walking" and "standing" were most frequently mentioned by individuals with pain (68 and 67%, respectively). These items were cited significantly more often by the chronic pain group than by the acute pain group, which suggests that such situations are particularly associated with chronic pain. As could be expected, these items were also cited significantly more often in the walking group than in the nonwalking group. Because chronic pain was more frequent in walking patients, we suggest that the latter are notably more likely to experience chronic pain when walking starts to become very difficult.
Pain Treatment
Our findings concerning the medical and physical pain treatments used and the apparent, resulting efficacies suggest that pain treatments are generally insufficient. Physical treatments, in particular, are not used enough. It is noticeable that certain treatments (such as acupuncture or manual therapy) were not even cited by the respondents.
Painkiller use was frequent (70%) but had a poor analgesic effect. The use of step 1 and step 2 analgesics was frequent in the population with pain (44 and 24%, respectively), but the analgesic effect seemed to be low (33 Ϯ 21 and 28 Ϯ 17, respectively). Strong opioids and narcotics were not frequently reported (9 and 4%, respectively) and tricyclic antidepressant use was not reported at all. Only two individuals with LGMD and SMD reported use of morphine. The increased use of opioids should certainly be considered, although digestive and respiratory side effects have to be taken in account.
Massage was the most frequently reported physical treatment (48%) and the average relief was 34 Ϯ 17, which is comparable with the relief procured by step 1 analgesic drugs. Balneotherapy, TENS, and ultrasound were not frequently reported (23, 10, and 7%, respectively).
Physical treatments are certainly of great potential interest in patients with NMD who report pain, but the efficacy of such procedures needs to be assessed by further studies in this type of population.
There is no consensus concerning pain treat-ment in patients with NMD, although a recent expert council made a few recommendations for the use of analgesics. 35 It reported that all types of analgesics are indicated as long as the side effects are anticipated. Thus, the analgesic effect of treatment needs to be better evaluated in NMD.
Study Limitations
Several important limitations of the study should be noted.
Population
The heterogeneity of the populations implicated a wider sample but certainly weakened the interpretation of the diagnostic group analysis. The absence of could not be affirmed because of the low size of these groups, and further study should include larger samples.
The population was heterogeneous in terms of diagnosis and motor deficiency. It included a group of acquired and inherited NMDs, and some diagnoses (such as ALS and Guillain Barre syndrome) were absent. Nevertheless, it was representative of an adult NMD patient population. In comparison with European and Japanese epidemiologic data, Hughes estimated that the most frequent myopathy in Northern Ireland is DMS, with a prevalence of 1 in 12,000, followed by DMD and BMD (1 in 17,000), congenital myopathies (1 in 28,600), CMT (1 in 32,000), FSHD (1 in 32,000), SMA (1 in 71,400), LGMD (1 in 90,900), metabolic myopathies (1 in 90,900), and mitochondrial myopathies (1 in 167,000). 3 DMD and BMD and congenital myopathies were less represented in our population because we only investigated adult patients. With a mean age of 40.9 yrs, this population did not reflect most patients with DMD and BMD, who unfortunately have a short life expectancy after the age of 18.
Methods
The survey was performed using a mailed, 23page questionnaire. The low response rate (45%) can probably be explained by the dissuasive effect of the high number of questions and could have been improved by a follow-up letter. Moreover, the low response rate limits the generalizability of the finding. In the future, clinical survey should include pain evaluation. It would improve the interpretation of postal surveys, which are limited by the patient subjectivity with self-completion questionnaires.
Functional Ability
The use of the Brooke and Vignos scales in DMD has been described. These tools show low sensitivity for muscle strength evaluation, because walking is possible even when muscle strength is impaired by up to 90%. 36 The data need to be validated in other diagnoses and with a self-completion questionnaire, this implicates that functional results of our study are limited. Nevertheless, the scales indicated results that are in line with what could be expected in this type of population. Functional scale analysis showed that scores for patients with LGMD, MSA, and DMD and BMD were less than 5 out of 9 (corresponding to some major ambulatory difficulties), whereas patients with CMT, FSHD, and DMS had higher scores (nearer to 7 out of 9). This is what can be expected for the degree of muscle impairment usually observed in these pathologies. The Brooke and Vignos upper and lower limb functional scales would therefore probably be useful in a self-completion questionnaire format and should be validated in this respect.
Although the HADS scale has shown good reliability and sensitivity in a population affected by diagnoses other than NMD, its psychometric properties in individuals with NMD have yet to be established.
Unlike the survey by Jensen et al., 8 our study did not investigate quality of life. It would have been interesting to collect this information, but it would probably also have been difficult to differentiate the respective influences of functional disability and pain on quality of life in patients with NMD.
CONCLUSION
The present study shows that patients with NMD report frequent chronic pain and that they are undertreated. Musculoskeletal problems and the efficacy of pain relief need to be better evaluated in this population.
